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EMVIThe high rate of local recurrence is considered the major concern and challenge regarding the surgical
treatment of cancer rectum. The target of use of pre-operative neoadjuvant therapy is reducing tumour
size and improving its resectability in order to reduce local recurrence risk and improve survival rates.
Plans for management and treatment of locally advanced rectal cancer showed clear changes after use
of neoadjuvant therapy. This in turn necessitates accurate evaluation of the tumour parameters before
and after use of combined chemotherapy and radiation therapy (CRT).
Aim of study is to assess the initial stage of cancer rectum then its response to neoadjuvant therapy
using MRI, prior to operative interference. This is followed by post-operative histo-pathological data cor-
relation.
Methods: This study was conducted on 50 patients. All patients were examined by high-resolution T2-
weighted images. Turbo-spin-echo sequences taken in sagittal plane, axial plane perpendicular to tumor
axis and coronal plane parallel to tumor axis or anal canal. All are according to tumor height. Diffusion
weighted images (DWI) performed in all cases.
Results: Following neoadjuvant therapy, down-staging was detected in this study in more than 90% of
patients regarding the T2 signal and apparent diffusion coefficient (ADC) value of the tumour, also status
of depth of involvement of meso-rectal fascia (MRF), circumferential resection margin (CRM), extra-
mural vascular invasion (EMVI) and nodal involvement.
Conclusion: Pre-operative MRI in cancer rectum is irreplaceable to assess initial staging and post-
neoadjuvant therapy response thus improving surgical results.
 2018 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The high rate of local recurrence is considered the major con-
cern and challenge regarding the surgical treatment of cancer rec-
tum. The target of use of pre-operative neoadjuvant therapy is
reducing tumour size and improving its resectability in order to
reduce local recurrence risk and improve survival rates.1
Plans for management and treatment of locally advanced rectal
cancer showed clear changes after use of neoadjuvant therapy. This
in turn necessitates accurate evaluation of the tumour parameters
before and after use of combined chemotherapy and radiation
therapy (CRT).21.1. Tissue characteristics
On T2WI, the viable tumour tissue exhibits typically intermedi-
ate signal intensity; that is expressing the signal intensity between
the muscularis propria and mucosa.3 Rectal mucinous adenocarci-
noma (RMAC) is admixed with areas of high SI of mucin.4
DWI-MRI plays an important role in visual identification of the
tumour based on high signal intensity and also quantitative data
based on tissue cellularity of which based on low ADC value. Also
the ADC value has an established role in evaluation and monitoring
of tumour tissue response following neo-adjuvant therapy.5
1.2. Distal resectability
According to the distance of the lowest edge of the tumour from
the anal verge which is considered to be useful reference point for
Table 5
Distribution of patients according to MRI detailed characteristics of positive MRF
involvement.




Nodal lesions & MRF Positive 39 86.7
Table 2
Distribution of patients according to initial TNM staging.
TNM Stage Number of patients % of total











Metastasis (M) M0 45 90
M1 5 10
Table 4
Distribution of patients according to initial status of sphincteric mechanism.





Internal sphincter only invaded 9 18
Internal sphincter invaded together with inter-
sphincteric plane (IP).
4 8
Internal & external sphincters invaded 7 14
Total 50 100
Table 3
Distribution and initial specific staging of patients with ano-rectal tumors.






662 E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678the surgeons, the height of the tumour is described and classified as
upper, middle and lower rectal tumors.6
Initial pre-treatment MRI in rectal cancer must define the status
of the sphincteric complex in low rectal tumours, whether it’s
invaded or not. Following CRT, abdomino-perineal resection proce-
dures can be replaced with ultralow resection followed by colo-
anal anastomosis.7
1.3. Circumferential resectability
Staging of rectal cancer using MRI is precisely based on identi-
fication of T2 signal intensity differences between the tumour, sub-
mucosa, muscular layer, and meso-rectum.8 According to the
extra-mural depth of tumour spread beyond muscular propria into
meso-rectal fat, the more recent rectal cancer staging from the
American Joint Committee on Cancer (2010) and MR imaging clas-
sification proposed by Smith and brown concerned T3 tumours
sub-classification.8 Smith and brown TNM staging.
Further specific T staging for low rectal tumours is performed
using evaluation of the coronal T2-weighted images.9 Ano-rectal
staging.
Evaluation of the mesorectal nodes, nodules as well as
extramesorectal adenopathies: It is essential to define any suspi-
cious regional pelvic lateral side wall lymph node and describe
its exact location, number, size and shape in T2WI. Also detection
of any other non-regional extra-mesorectal nodes is essential
(considered as M1) including common and external iliac nodes,
para-aortic nodes, obturator nodes and lastly inguinal nodes in
low rectal tumors.10
Extramural vascular invasion (EMVI): Presence of malignant cells
in the meso-rectal fat blood vessels beyond the muscularis propria
refers so as to be EMVI.11
Circumferential resection margin (CRM) and Distance from
mesorectal fascia (MRF): Any tumour lying within 1 mm of MRF is
considered positive CRM. It is essential to describe its location pre-
cisely using axial T2WI in clock wise direction.12
Desmoplastic reaction: This can be defined by the presence of any
low T2 signal tumor speculations projecting into meso-rectal fat.11
Evaluation of anterior peritoneal reflection: It is essential to
describe relation of the tumour tissue (mainly middle and upper
rectal neoplasms) to anterior peritoneal reflection. Invasion of
which is considered T4a tumour and carries high rate of
recurrence.11
Evaluation of pelvic side wall and other pelvic organs: It is essen-
tial also to depict any invasion of the pelvic organs which is consid-
ered as T4b tumor. Urinary bladder and uterus can be invaded in
cased of upper or middle rectal neoplasms. While lower rectal
tumours can invade the levator muscles, the prostate, the vagina,
the seminal vesicles, the sacrum, and coccyx.3,6
1.4. Post neoadjuvant CRT MRI changes and tumour regression grading
(TRG)
Schematic presentation of MRI tumour regression grading (TRG)
was performed based on tumour volume and changes of T2 signalTable 1
Distribution of patients according to location of the tumour.
Location of tumour Number of patients % of total
Upper rectum (>10 cm) 6 12
Middle rectum (5–10 cm) 14 28
Lower rectum (<5 cm) 2 4
Mixed (upper and middle) 6 12
Mixed (middle and lower) 1 2
Diffuse ano-rectal 21 42
Total 50 100with either low signal depicting tumour fibrosis or high signal
depicting mucin.11 Dworak Tumor regression grade.
It is essential to detect any morphologic changes following CRT
regarding the tumour, rectal wall, tumour-mesorectal fat interface,
metastatic lymph nodes and EMVI. These morphological changes













Not invaded 42 84
Surrounding viscera Invaded 7 14
Not invaded 43 86
E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678 663response. Also it is important to depict the inflammatory morpho-
logical changes including sub-mucosal edema, tissue necrosis and
pseudo-tumour.132. Aim of the work
To assess to the initial stage of cancer rectum then its response
to neoadjuvant therapy using MRI, prior to operative interference.
This is followed by post-operative histo-pathological data
correlation.Case 1: 
Fig. 1. (Initial MRI study): A 62 years old male patient presented with bleeding per rectu
using sonographic gel; (a) and (b) Sagittal high resolution T2WIs showing the lower rect
resolution T2WIs showing the rectal mass with intermediate signal intensity extending
the internal sphincter from 11 to 1o’clock (green arrow). (e) Coronal high resolution
hypointense signal of the rectal mass denoting restricted diffusion (0.8  103 mm2/s).3. Patients and methods:
This retrospective study included 50 patients with rectal carci-
noma. All patients were imaged using external phased array sur-
face coils on 1.5 T superconducting magnet MRI machines
including 2 patients imaged by Philips Gyroscan Intera (Best, The
Netherlands), 2 patients imaged by GE Signa HDxt (Milwaukee,
USA) and 46 patients imaged by Siemens Magnetom Avanto
(Erlangen, Germany).
This study was limited to patients having rectal cancer diag-
nosed by either CT colonography or endoscopy and histopathology.m and the PR examination revealed a rectal mass. MRI study with rectal distension
al mass lesion (red arrows) about 3.5 cm from the anal verge. (c) and (d) Axial high
from 9 to 3o’clock, no extension beyond the muscularis propria with implication of
T2WI showing extension 8 mm below puborectalis sling. (f) ADC map showing
The preliminary imaging based staging was c T2 N0.
664 E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678High-resolution T2-weighted images were obtained using non-
breath hold turbo-spin-echo sequence. According to tumour
height, all planes were examined including; sagittal plane, axial
plane perpendicular to tumor axis, coronal plane parallel to tumor
axis or anal canal. Diffusion weighted images (DWI) were also
obtained in the axial plane. Rectal luminal distension using sono-
graphic gel done when needed in some cases.
A post neoadjuvant therapy follow upMRI study was performed
in all patients after 6–8 weeks (with the same above mentioned
sequences).
Correlation with histo-pathological data carried out after the
surgical management.
Rectal cancer patients without the pre neoadjuvant therapy MRI
examinations were excluded from the study as adequate assess-
ment of response to neoadjuvant therapy will be limited.4. Results
4.1. Initial pre-neoadjuvant therapy staging of the tumor
The present work included 50 patients presented with rectal
carcinoma. They were 23 males and 27 females with near ratio
0.46:0.54 respectively. Their ages ranged between 20 and 80 years
with a mean age of 50 years. The peak age was targeting the 7th
decade. All patients considered the examination acceptable, with
no discomfort or complications reported.
Around 94% of these patients complained from bleeding per-
rectum while 86% of them complained also from altered bowel
habits. 70% of patients showed generalized symptoms of cachexia.
Abdominal pain was present in 32% of patients. None of these
patients presented by intestinal obstruction or distant organs
metastatic lesions of unknown primary.
According to distance of the lower border of the tumour from
ano-rectal junction (ARJ); tumour location is categorized into
either upper rectal neoplasm (>10 cm), middle rectal neoplasm
(5–10 cm), lower rectal neoplasm (<5 cm), widespread upper andFig. 2. (Post-neoadjuvant therapy MRI study): for the same patient after 5 months show
T2WI and ADCmaps, same dimensions and distal resectability features; resulting in TRG 5
T2WI and (b) ADC map showing the lower rectal mass lesion with the intermediate T2
diffusion. The patient performed abdominoperineal resection with the post-operative hi
10 nodes excised was free, margins free.middle involvement, widespread middle and lower involvement)
and diffuse ano-rectal involvement (Table 1).
Initial TNM staging of the tumour was performed in all patients
(Table 2).
Regarding (nodes-N); 43 patients showed suspicious metastatic
nodes. All of them exceeds 5 mm in short axis diameter. 36
patients of them showed irregular contour and internal necrosis.
Regarding (metastasis-M) determined by presence or absence
non-regional metastatic nodes or mesenteric soft tissue masses:
Stage M1 was depicted in five patients (10%), four of them with
non-regional metastatic looking lymph nodes.
Ano-rectal tumours were specifically staged into stage I to IV
(Table 3).
Low T2 signal of the tumour was found in four patients, while
intermediate signal was found in 40 patients, high and mixed sig-
nals were found in three patients each. ADC value of the tumour
found to be ranging from 0.4 to 1  103 mm2/s with mean value
0.7  103 mm2/s.
Sphincteric mechanism was intact in 30 patients. Invasion of
internal sphincter only found in nine patients. Invasion of internal
sphincter and IP was found in four patients. While invasion of both
external and internal sphincters was found in seven patients. CRM
was positive in 28 patients and negative in 22 patients (Table 4).
Only five patients showed negative involvement of the MRF
while 45 patients showed positive involvement; 39 patients
showed positive MRF depth of involvement via nodal lesions, 15
patients showed positive MRF depth of involvement and positive
EMVI, only eight patients showed initial invasion of the anterior
peritoneal reflections, also only seven patients showed initial inva-
sion of the surrounding viscera (Table 5).
13 patients initially had suspicious extra-mesorectal adenopa-
thies. Nine patients showed only regional extra-mesorectal suspi-
cious adenopathies. While four patients showed mixed regional
and non-regional extra-mesorectal suspicious adenopathies.
Regional nodes included inferior mesenteric artery (IMA) nodes
and internal iliac nodes while the none-regional nodes included
external iliac nodes, obturator nodes, inguinal nodes and para-
aortic nodes (see Figs. 1–14).ed a non-responding lower rectal mass lesion with same tissue characteristics at
and imaging based staging yc T2N0. Post CRT MRI study. (a) Sagittal high resolution
signal (red arrow in a) and ADC values about 0.8  103 mm2/s denoting restricted
stopathology revealed a moderately differentiated rectal adenocarcinoma, 10 out of
Case 2: 
Fig. 3. (Initial MRI study): A 66 years old male patient diagnosed as rectal mass and referred from the oncology department for initial staging. MRI study; (a) and (b) Sagittal
high resolution T2WIs, (c) and (d) axial high resolution T2WIs, (e) Coronal and (f) Axial high resolution T2WIs, (g) and (h) DWI and ADC maps showing a low third rectal mass
lesion with intermediate SI, about 2.7 cm from the anal verge, crossing the puborectal sling by 7 mm, involving the four quadrants circumferentially with focal interruption of
the musculosa at 9o’clock (red arrow in c) and implication of the upper 7 mm of the internal sphincters from 11 to 1o’clock (green arrows in d). An extramesorectal regional
right internal iliac suspicious node is noted (blue arrow in f). Resticted diffusion was noted at DWI with ADC values about 0.8  103 mm2/s. The preliminary imaging based
staging is cT3a (below APR, CRMve) Nx, stage 2 anal complex invasion.
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Regarding tumour regression grade (TRG): according to TRG;
down staging was classified into five categories. 41 patients (after
first course of neoadjuvant therapy) and overall 45 patients (afterFig. 4. (Post-neoadjuvant therapy MRI study): after 4 months revealed marked therap
Spared sphincters. The preliminary imaging based staging is yc T0-2N0. MRI study with r
Axial high resolution T2WIs, (c) Coronal high resolution T2WI, (e) and (f) DWI and AD
denoting fibrosis, 6 cm from the anal verge, involving three quadrants circumferentially (
c). The pathologically enlarged nodes. DWI showed no restriction. The patient perfo
differentiated rectal adenocarcinoma, Mandrad grade 2 with 7 out of 7 nodes excised fradditional clinically indicated course) that showed TRG1,2&3
expressed significant elevation of the ADC value. 13 patients of
them showed no tumor. 16 patients of them showed pure low T2
signal due to post-management fibrotic changes. 12 patients
showed mixed low T2 signal of the fibrotic response and interme-eutic Response (TRG = 2: Dense fibrosis with absent or minimal residual disease).
ectal distension using sonographic gel. (a) Sagittal high resolution T2WI, (b) and (d)
C maps showing the lower third rectal lesion currently displaying low SI at T2WI
red arrow in b) with no implication of the anal sphincteric complex (best depicted in
rmed low anterior resection (LAR) with the histopathology revealed moderately
ee, margins free and donuts free.
E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678 667diate signal of the residual tumor, 3 patients showed high T2 signal
due to edema and mucinous changes, meanwhile 1 patient showed
mixed low and high T2 signal. Further neo-adjuvant therapy ses-
sions were clinically indicated and prescribed for two patients with
TRG4 and four patients with TRG5 (Table 6).
ADC value of the tumour found to be ranging from 1 to 1.2 
103 mm2/s in 45 patients with mean value 1.1  103 mm2/s.
Regarding nodal disease; five patients showed stationary nodal
disease, 12 patients showed regressive course while 26 patients
showed totally resolved previous nodes, confirmed by DWI.
Regarding extra-mesorectal nodes; five patients with suspicious
extra-mesorectal adenopathies showed stationary nodal disease,Case 3: 
Fig. 5. (Initial MRI study): A 67 years old male patient presented with bleeding per rectu
high resolution T2WI, (c) and (d) axial high resolution T2WI, (e) and (f) DWI and ADC ma
b), about 3 cm in maximum length, 10.8 cm from the anal verge and 5.6 cm from th
extramural depth of invasion (EMDI) beyond the muscularis propria into mesorectal fat.
0.8  103 mm2/s. The preliminary imaging based staging is c T3b Nx. Opposite to APRtwo patients showed regressive course while six patients showed
totally resolved previous nodes.
Regarding CRM; five patients showed persistent positive CRM
(three of them showed local recurrence and distant omento-
peritoneal spread with high morbidity in further post-
operative follow up CT studies) while 45 patients showed neg-
ative CRM.
Regarding EMVI; four patients showed persistent positive EMVI
while 46 patients showed negative EMVI.
Regarding status of surrounding viscera; three patients showed
persistent positive invasion of the surrounding viscera while 47
patients showed clear fat plane of cleavage (Table 7).m and diagnosed as rectal mass by endoscopy. Initial MRI study; (a) and (b) Sagittal
ps showing an upper rectal mass lesion, opposite to the spared APR (yellow arrow in
e puborectalis sling, extending circumferentially from 7 to 12o’clock with 4 mm
Restricted diffusion is seen in DWI with hyperintense signal and ADC values about
and CRM spared.
668 E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678Types of operations: According to surgical management and
choice of operations; LAR was performed in 18 patients, while left
hemi-colectomy and LAR were done to seven patients, trans-
sphincteric procedure done to one patient, TME done to ten
patients and APR done to 14 patients.
4.3. Correlation to post-operative histo-pathological laboratory results
Nine patients showed positive nodal disease; only seven of
them were reported positive in MRI. Four patients showed positive
extra-mesorectal adenopathies (all reported positive in MRI. Only
two patients showed positive resection margin while 48 patients
showed negative resection. Four patients showed positive EMVI
(three of them were positive in MRI and one not). Only two
patients showed positive invasion of the surrounding viscera (both
reported in MRI).
4.4. Statistical analysis following correlation of post-neoadjuvant MRI
findings and post-operative histo-pathological laboratory data
MRI showed high specificity for detection of EMVI and invasion
of surrounding viscera and high sensitivity for detection invasion
of surrounding viscera, meanwhile it showed moderate sensitivity
for detection of EMVI, also moderate specificity and sensitivity for
detection of nodal response (Table 8).Fig. 6. (Post-neoadjuvant therapy MRI study): The post-neoadjuvant CRT MRI study afte
preliminary imaging based staging is yc T1 or T2 N0. Post neoadjuvant MRI study; (a) an
maps showing the previously noted upper rectal mass lesion, currently regressed in size
circumferentially from 7 to 9o’clock with no evident of EMDI at current study, foci of r
performed left hemicolectomy with low anterior resection. The post-operative histopath
nodes excised were free, margins free.5. Discussion
Keeping with Taylor,6 localized affection of either upper, middle
or lower thirds of the rectum was found in this study in 44% of
patients, while 56% of our patients showed widespread involve-
ment of different parts of the rectum and 42% of patients that
showed diffuse ano-rectal involvement.
Also keeping with Smith & Brown who had described in details
the TNM staging of cancer rectum 6 and regarding the tumour (T)
of the TNM staging; T2, 3 and 4 stages were included in this study.
T3c stage was predominant, seen in 30% of our patients. N0, 1 and 2
stages were also included in this study; N2b stage was predomi-
nant seen in 58% of our patients.
21 patients in this study that showed diffuse ano-rectal involve-
ment had further staging and 42.9% of them showed stage 4. Ini-
tially intact sphincteric mechanism was seen in 60% of patients
while isolated internal sphincteric involvement (stage 1,2) was
seen in 18% of patients, involvement of the internal sphincter
and inter-sphincteric plane (stage 3) was seen in 8% of patients
and deep involvement of both internal and external sphincters
(stage 4) was seen in 14% of patients. This was totally keeping with
Shihab 9 who described the further staging of ano-rectal carcinoma
with stage III depicts invasion of more than 1 mm of the inter-
sphincteric space and stage IV means invasion of the external
sphincter or beyond.r 4 months revealed partially responding upper third rectal neoplasm (TRG = 3). The
d (b) Sagittal and axial high resolution T2WI respectively, (c) and (d) DWI and ADC
about 2 cm in maximum length and 8.7 mm in maximum thickness, extending from
estricted diffusion was seen with ADC values about 0.8  103 mm2/s. The patient
ology revealed moderately differentiated rectal adenocarcinoma, with 14 out of 14
Case 4: 
Fig. 7. (Initial MRI study): A 51 years old female patient diagnosed as rectal mass and referred from the oncology department for initial staging. Initial MRI with rectal
distension using sonographic gel. (a) Sagittal high resolution T2WI, (b), (c) and (e) Axial high resolution T2WI, (d), (f) Coronal high resolution T2WI, (g) and (h) DWI and ADC
maps showing an upper rectal mass lesion, about 5 cm in maximum length, 10 cm from the anal verge, showing intermediate signal intensity with involvement of the four
quadrant of the rectal wall circumferentially. EMDI is noted all around the rectal wall with about 2 mm from the MRF at 8o’clock (red arrow in b). Suspected EMVI is noted at
9o’clock (yellow arrow in c). Multiple mesorectal adenopathies were seen (blue arrow in c, d, e) around the tumor and averaging 6 mm in size with some abutting the
mesorectal fascia (red arrow in e). Inferior mesenteric extramesorectal regional node was seen, averaging 7 mm im size (green arrow in f). Restricted diffusion noted with ADC
about 0.8  103 mm2/s. Preliminary imaging based staging is c T3c N2b (CRM+).
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surveillance (M0), while 10% showed positive metastatic disease
(M1) seen in five patients; four of them depicted by non-regionalextra-mesorectal metastatic nodes including external iliac nodes,
obturator, inguinal and para-aortic nodes (each depicted in one
patient). In our study, the morphology of the affected nodes was
Fig. 8. (Post-neoadjuvant therapy MRI study): Post neoadjuvant CRT MRI study after 4 months revealed complete radiological response (TRG 1) yc T0-2N0. Post neoadjuvant
CRT MRI with rectal distension using sonographic gel. (a), (b) and (c) Sagittal, coronal and axial high resolution T2WIs respectively showing complete response of the rectal
mass lesion with no EMDI, EMVI or pathologically enlarged mesorectal nodes noted. The patient performed low anterior resection (LAR) with post-operative histopathology
revealed a moderately differentiated rectal adenocarcinoma with Mandrad grade 1, 10 out of 10 nodes excised were free, Donuts free and margins free.
670 E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678more important than their size. 83% of patients with affected nodes
showed irregular speculated contours with internal necrotic foci,
while all patients showed increase in their size (>5 mm). These
signs were seen in both the regional meso-rectal as well as
extra-mesorectal adenopathies. According to Allen,14 the regional
nodal spread in cancer rectum to involve; superior, middle, inferior
and peri-rectal, pre and lateral sacral, sigmoid and inferior mesen-
teric as well as internal iliac nodes. Other nodes are considered
non-regional and metastatic.
In this study, initially intermediate T2 signal of the tumour was
predominant seen in 80% of patients. While initially low ADC value
of the tumour ranging from 0.4 to 1  103 mm2/s was also charac-
teristic (mean = 0.7  103 mm2/s). Chun3 had also described that
viable rectal tumour initially exhibit intermediate T2 signal
between the signal intensity of the muscularis propria and mucosa.
Extramural depth of invasion (EMDI) was assessed in our study
according to the classification of T3 tumours to T3a, T3b, T3c and
T3d with or without implication of meso-rectal fascia by the rectal
wall tumour itself. EMDI was identified by the extension of the
intermediate signal intensity of the tumour beyond the outer low
signal intensity layer of the muscularis propria within the hyper-
intense meso-rectal fat. Associated desmoplastic reaction was
described in some of the cases in our study as hypo-intensespeculations around the rectal wall tumour within the meso-
rectal fat with accurate clock wise description mentioned.
In this study: Initially positive MRF depth of involvement was
seen in 90%; 86.7% of them showing positive nodal involvement,
only 33.3% showing positive EMVI. Invasion of the anterior peri-
toneal reflection was depicted only in 16% of our patients and inva-
sion of the surrounding viscera was depicted only in 14%. Finally at
initial pre-management evaluation, 56% of patients showed ini-
tially positive CRM while 44% were negative.
Extramural vascular invasion (EMVI) is an important indepen-
dent risk factor for local and distant recurrence and was seen
mostly associated with T3 tumours in our study. Normally the
meso-rectal vein was seen as fine linear hypo-intensities within
the meso-rectal fat all around the rectal wall. In our study EMVI
was identified by the expansion of meso-rectal veins with the
intermediate signal intensity of the rectal mass. Nodularity of the
affected vein was seen in more severe cases denoting invasion
beyond the wall of the affected veins resulting in the so called ‘‘tu-
mour deposits” within the meso-rectal fat.
Distance of the rectal wall tumour or the EMVI or enlargedmeso-
rectal nodes fromthemeso-rectal fascia is importantdependent fac-
tor for operative decision i.e either sphincter saving procedures
would be accomplished or not because the meso-rectal fascia is
Case 5: 
Fig. 9. (Initial MRI study): A 49 years old male patient diagnosed as rectal mass and referred from the oncology department for initial staging. Initial MRI study; (a) and (g)
Sagittal high resolution T2WI, (b) through (f) Axial high resolution T2WI, (h) ADC maps showing a middle third rectal mass lesion, about 7.5 cm in maximum length, 7.8 cm
from the anal verge, showing internal signal mixed with areas of cystic necrosis, involving four quadrants circumferentially; from 10 to 7o’clock. Sizable EMDI was seen with
exophytic lesion about 3.2 cm in size extending from 2 to 5o’clock and invading the MRF (red arrow in b). EMVI noted at 4o’clock (yellow arrow in c). Multiple mesorectal
adenopathies noted (blue arrow in d) abutting the MRF at 7o’clock (red arrow in d). Multiple extra mesorectal inferior mesenteric nodes were seen (orange arrow in e and f).
The APR was noted at the upper edge of the tumor, yet not infiltrated (pink arrow in g). Restricted diffusion with ADC values about 0.8  103 mm2/s seen. The preliminary
imaging based staging is c T3d N2, below APF, CRM involved.
E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–678 671considered as the surgical circumferential resection margin (CRM)
for the total meso-rectal excision (TME) which is an important part
of the recent advances in the rectal cancer surgeries. The circumfer-
ential resection margin (CRM) was said to be involved or positive if
tumoral tissue (either from the rectal wall its self or EMVI or
enlarged meso-rectal nodes) seen within 1 mm from the meso-
rectal fat. Positive CRMwas described in all of the cases in our study,
both in the initial and post neoadjuvant CRT MRI studies.
The anterior peritoneal reflection (APR) is an important entity
to be commented upon while assessing a case of rectal cancer as
its affection denoted T4a rectal tumours. It was identified as thin
linear hypo-intensity extending from the upper posterior border
of the urinary bladder dome to the junction of the upper two thirdand lower third of the rectum. In females, it had a variable attach-
ment; may be as low as 5 cm from the anal verge. In our study, it
was said to be affected if thick linear hypo-intensity was seen at
the anatomical site of the APR in the initial pre-neoadjuvant MRI
study. Its assessment in the post-neoadjuvant studies was done
in all of our cases to compare the status of its affection to the initial
study or whether post-irradiation changes had occurred, seen as
De novo hypo-intense thickening of the APF together with the
hypo-intense fibrotic response of the tumor.
Invasion of the surrounding viscera is an important entity to be
assessed in every case of rectal cancer as their affection denoting
T4b rectal tumours and requires additional interference of the
gynaecology or the surgical urology staff during the rectal cancer
Fig. 10. (Post neoadjuvant therapy MRI): Post neoadjuvant CRT MRI study after 4 months revealed markedly responding middle rectal mass lesion . . .Markedly responding
middle third rectal mass (TRG 2), ve CRM, preliminary imaging based staging yc T0-2N0 Mx. Post neoadjuvant MRI study; (a) Sagittal high resolution T2WI, (b), (c) and (d)
Axial high resolution T2WI, (e) and (f) DWI and ADC maps showing markedly responding middle rectal mass lesion, about 4 cm in length, 11 cm from the anorectal junction,
showing predominantly hypointense SI denoting fibrotic response. The previously noted EMDI replaced by hypointense fibrotic strands (blue arrow in d), contiguous with
MRF (red arrow in c). No definite diffusion restriction with ADC values 1  103 mm2/s. The patient performed total mesorectal excision (TME) with post-operative
histopathology revealed a moderately differentiated rectal adenocarcinoma, 8 out of 8 nodes excised were free with fibrotic strands, Donuts free, margins free.
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management MRI assessment is keeping with statement of MER-
CURY study group15 who reported that clearance or involvement
of the surgical resection margin could be accurately performed
using high resolution MRI.
Following neo-adjuvant therapy, down-staging took place in
more than 90% of patients in this study. TRG2&3 was predominant,
each seen in 32% of patients, both showing either low T2 signal of
the tumour because of fibrosis or high T2 signal of the tumour
because of edema, also both showing relative elevation of the
ADC value and relative non-restriction. 26% of patients showed
TRG1 and only 10% showed minimal or no improvements
(TRG4&5). Describing the response of the rectal wall tumour to
the neoadjuvant therapy in our study, the rectal wall tumourseither showed total resolution with no evidence of rectal wall
tumour or hypo-intense signal replacing the intermediate SI denot-
ing fibrotic response; associated with thick hypo-intense scarring
contiguous with meso-rectal fascia or thin linear fibrotic reaction
within the meso-rectal fat. Colloid or mucinous response of the
rectal mass lesion was seen all well.
This study showed significant relation between elevation of the
ADC value of the tumour denoting relative non-restriction (ranging
1–1.2  103 mm2/s, with mean value 1.1  103 mm2/s) and
degree of tumour response to CRT and this is totally keeping with
Kim16 who concluded that adding DWI to conventional MRI is
important to increase accuracy of evaluation of post CRT tumour
response and also keeping with Nougaret2 who confirmed the
above mentioned relation and in addition they use single-section
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ments bias. Sun17 also clarify that DWI importance is also extend-
ing to involve detection of response as early as possible. Also
Blazic5 who stated that post-CRT evaluation of the ADC value
should extend to involve the whole volume including areas of
necrosis and fibrosis in order to verify the complete response of
the tumour.
Regarding the overall nodal response following neo-adjuvant
therapy in this study, we found total resolution of affected nodes
in 60.5% of patients, size regression in 27.9% while only five
patients showed stationary course (11.6%). Van Heeswijk18 stated
that DWI is a reliable method for assessment of nodal involvement
in rectal cancer patients and DWI free image from nodal involve-
ment could be accurately used to diagnose nodal free status (N0).
Regarding the extra-mesorectal nodal response following neo-
adjuvant therapy among the affected 13 patients in this study,
we found total resolution of affected nodes in six patients in DWI
(46.2%), size regression in two patients (15.4%) while only fiveCase 6: 
Fig. 11. (Initial MRI study): A 54 years old male patient presented with bleeding per
distension using sonographic gel; (a) through (d) Sagittal high resolution T2WI, (e), (g), (i
ADC maps all showing a rectosigmoid mass lesion, about 6.3 cm in maximum length, 3.2
SI, its upper 2/3 involving the rectal wall circumferentially while its lower third involvi
beyond the MP with invasion of the MRF (best depicted in e and f). Its upper 2/3 was asso
was seen thickened (yellow arrow in d). EMVI was noted at 5o’clock (blue arrow in g). Mu
adenopathies were noted, some abutting the MRF (red arrow in j). Resticted diffusion was
T4a N2 Mx, +ve CRM, infiltrated APR.patients showed stationary course (38.4%). We agreed to Lee19
who emphasize on the fact that metastatic nodal sterilization is
the main factor determining process of down-staging.
In this study, post-operative histo-pathological assessment
revealed that seven patients out of 17 (41.1%) showed positive
overall nodal involvement and also two patients reported as
negative MRI showing positive affection. Post-operative histo-
pathological assessment also revealed that four patients out of
seven (57.1%) showed positive extra-mesocolic nodal involvement,
all reported in MRI. Statistical analysis of this study after correla-
tion to post-operative histo-pathological evaluation regarding the
nodal involvement revealed that MRI had 77.8% sensitivity and
75% specificity while positive predictive value accounts for 41.2%
and negative predictive value accounts for 93.9%. According to
Lahaye20, discrepancy between MRI and histo-pathological results
regarding the positively MRI reported nodes could be either due to
any of the following scenarios. First, False interpretation of a small
vascular structure or fibrotic area as a lymph node. Second, the realrectum and diagnosed as rectal mass by endoscopy. Initial MRI study with rectal
), (j) and (k) Axial high resolution T2WI, (f) and (h) Coronal high resolution T2WI, (l)
cm in maximum thickness, about 14 cm from the anal verge, showing intermediate
ng the rectal wall from 8 to 4o’clock. EMDI was noted at lower third about 16 mm
ciated with extramural component about 3  3 cm in size infiltrating the APR which
ltiple mesorectal (green arrows in i and j) and inferior mesenteric (pink arrow in k)
noted with ADC values about 0.8  103 mm2/s. Preliminary imaging based staging
Fig. 11 (continued)
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assessment. Third, real nodes are found during histo-pathological
assessment but showing equivocal characteristics.
Regarding the CRM status following neo-adjuvant therapy in
this study; 23 patients out of pre-management positive 28
patients (82%) showed negative post-management CRM status
and only five patients showed persistent positivity (among those
we found three patients to have local recurrence and distant
omento-peritoneal tumour spread in further post-operative fol-
low up CT studies). In this study, post-operative histo-
pathological assessment revealed that two patients showed pos-
itive resection margin. Again we confirmed statement of LEE19
who reported that we face much better outcome in those
patients who showed negative conversion of initially positive
CRM following neo-adjuvant therapy, while those who showed
persistently positive CRM face worse outcome with higher rate
of recurrence, morbidity and mortality.
Regarding the EMVI following neo-adjuvant therapy in this
study; 11 patients out of 15 (73.3%) showed total resolution and
only four patients showed persistent affection. Post-operative
histo-pathological assessment revealed that four patients showed
EMVI; one of them was negative in MRI. Regarding the EMVI
involvement, statistical analysis revealed that MRI had 75%sensitivity and 97.8% specificity while positive predictive value
accounts also for 75% and negative predictive value accounts for
97.8%. According to Patel13, good response to CRT will be mani-
fested by disappearance of EMVI or replacement by low signal
intensity fibrotic streaks within mesorectal fat.
Regarding the invasion of the surrounding viscera following
neo-adjuvant therapy in this study; one patients out of four
showed total resolution and three patients showed persistent
affection in MRI. Post-operative histo-pathological assessment
revealed that two patients showed only positive invasion of the
surrounding viscera, both reported in MRI. Hence statistical analy-
sis revealed that MRI regarding invasion of surrounding viscera
had 100% sensitivity and 97.9% specificity while positive predictive
value accounts for 67.7% and negative predictive value accounts for
100%. According to Dresen21, Pre-operative MRI evaluation of
tumour invasion of the surrounding pelvic visceral structures
showed 53–100% positive and 93–100% negative predictive values,
hence pre-operative MRI evaluation is considered accurate imaging
tool for prediction of absence of invasion of the surrounding pelvic
visceral structures.
From our study we concluded that for accurate and systematic
evaluation of a case of rectal cancer (pre or post CRT assessment),
should fulfil the following items: (Table 9).
Fig. 12. (Post neoadjuvant therapy MRI): after 2 months revealed moderately responding rectosigmoid mass (TRG 3) with infiltrated APR, +CRM, preliminary imaging based
staging T4a N2 Mx. MRI study with rectal distension using sonographic gel. (a) and (b) Sagittal high resolution T2WI, (c), (f) and (g) Axial high resolution T2WI, (d) and (e)
Coronal high resolution T2WI, (h) ADC maps all showing moderately responding rectosigmoid mass lesion, still averaging 6 cm in length and 14 cm from the anal verge, but
its maximum thickness regressed to 1.6 cm. it showed mixed intermediate and hypointense signal denoting fibrotic changes. The EMDI noted at its lower third regressed to 8
mm with multiple fibrotic strands contiguous with the MRF (red arrow in c); best depicted in c and d. Regression of the extramural component at its upper 2/3 was noted as
well, averaging 2  1 cm in size still infiltrating the APR (best depicted in e). Regression in size of the inferior mesenteric (yellow arrow in f) and mesorectal adenopathies
(green arrow in g) were seen; with distance from MRF about 2 mm. Small foci of restricted diffusion were noted with ADC values about 0.9  103 mm2/s. The patient
performed trans-sphincteric resection with coloanal anastomosis, the post-operative histopathology revealed a moderately differentiated rectal adenocarcinoma, 8 out of 12
nodes excised showed malignant cells, ve EMVI with margins free.
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Case 7: 
Fig. 13. (Initial MRI study): A 59 years old female patient presented with bleeding per rectum and diagnosed as rectal mass by endoscopy. Initial MRI study with rectal
distension using sonographic gel. (a) Sagittal high resolution T2WI, (b) Coronal high resolution T2WI, (c) and (d) Axial high resolution T2WI, (e) and (f) DWI and ADC maps
showing a lower rectal and upper anal mass lesion, about 5.3 cm in length, 3 cm in maximum thickness and about 3.3 cm from the anal verge with intermediate T2IW SI.
Suspected infiltration of the puborectalis on the right side (9o’clock) was noted (yellow arrow in b). Infiltration of the rectal wall anteriorly was noted opposite to 10–
11o’clock with loss of fat plane between the lesion and the posterior vaginal wall raising the possibility of local infiltration (red arrows in c). A mesorectal node showing low
signal but suspicious spiculations of its contours was seen at 11o’clock (blue arrow in d). Restricted diffusion was depicted with ADC values about 0.6  103 mm2/s. The
preliminary imaging based staging is c T4b N2.
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Fig. 14. (Post neoadjuvant therapy MRI): Post neoadjuvant CRT MRI study after 3 months revealed: . . .Complete radiologic response. No evidence of residual tumor on
imaging basis: Grade 1 tumor regression grade. Imaging based staging yc T0-2N0. Post neoadjuvant MRI study with rectal distension using sonographic gel. (a), (b) and (c)
Sagittal, Coronal and Axial high resolution T2WI respectively (d) ADC maps all showing total resolution of the rectal mass lesion with no suspicious adenopathies, areas of
diffusion restriction or pelvic organ infiltration. The patient performed abdomino perineal resection with the post-operative histopathology revealed moderately
differentiated rectal adenocarcinoma, Perineal invasion +ve, 2 out of 9 nodes excised showed malignant cells, EMVI ve, circumferential resection margin free.
Table 6
Distribution of patients according to TRG (tumour response after initial and further indicated post-Neoadjuvant therapy).
TRG TRG1 TRG2 TRG3 TRG4 TRG5 Total
No % No % No % No % No % No %
Initial course 13 26 16 32 12 24 4 8 5 10 50 100
Further indicated course 13 26 16 32 16 32 4 8 1 2 50 100
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Table 7
Distribution of patients according to post-Neoadjuvant therapy response.
Post-neoadjuvant Response No. of patients % of total
Overall nodal response Stationary 5 11.6
Regressing 12 27.9
Resolved 26 60.5
Extra-mesorectal nodal response Stationary 5 38.4
Regressing 2 15.4
Resolved 6 46.2
CRM status Positive 5 10
Negative 45 90
EMVI status Positive 4 8
Negative 46 92
Surrounding viscera Invaded 3 6
Clear 47 94
Table 8
Sensitivity, specificity and predictive values of the MRI:




Sensitivity % 77.8 75 100
Specificity % 75.1 97.8 97.9
Positive predictive value % 41.2 75 67.7
Negative predictive value % 93.4 97.8 100
Table 9




b. ADC value (103 mm2/s)
c. Modified Dworak tumour regression grading
(TRG) (in post-neoadjuvant study)
(II) Dimensions a. Length (in cm)
b. Maximum thickness (in cm)
(III) Distal
resectability
a. Lower edge of tumour to anal verge (in cm)
b. Lower edge of tumour to top of puborectalis
muscle (in cm)




a. Circumferential extent (quadrant/s involved)
b. Extramural depth of invasion (EMD) (distance
and location)
c. Meso-rectal nodes and nodules (their num-
ber, location in clockwise manner, size and
morphology)
d. Extramural vascular invasion (EMVI) (Loca-
tion in clock wise manner)
e. Distance from the meso-rectal fascia (i.e cir-
cumferential resection margin; CRM involved
or not by the rectal wall tumour or EMVI or
nodes and its clock wise location)
f. Anterior peritoneal refection (APR) (involved
or spared)
g. Pelvic side walls (obturator internus and pyri-
formis muscles, parietal fascia as well as com-




a. Extra-mesorectal adenopathies (location, size
and morphology)
b. Other pelvic viscera: (affected or spared)
c. Pelvic collection (if present)
d. Bone marrow signal
(VI) Final diagnosis Including imaging based preliminary TNM staging
with CRM +/ regarding its implication, APR
involvement if present, extra-mesorectal
adenopathies with the TRG in the post neoadjuvant
study
678 E. El-Kady et al. / Alexandria Journal of Medicine 54 (2018) 661–6786. Conclusion
MRI is irreplaceable for initial staging of cancer rectum and
evaluation after neoadjuvant therapy to detect tumour response
grade which greatly affect the choice of the operation plan and
decrease local recurrence thus improving surgical results and sur-
vival rate.
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